The special AT-rich sequence-binding protein 2 (SATB2), a nuclear matrix-associated
transcription factor and epigenetic regulator, was identified as a tissue type-specific protein …

Objectives Immunohistochemistry is an important extension to clinical information and
morphology, and prevails as an invaluable tool for establishing a correct cancer diagnosis in …

To identify novel biomarkers of metastasis of colorectal cancer (CRC), we developed an
orthotopic implantation model of murine CRC and selected in vivo M5, a subclone of the …

SATB2 is part of the family of matrix attachment region–binding transcription factors, and has
developmental roles in craniofacial, neural, and osteoblastic differentiation. Recently …

Background and aims To date, the association between special AT-rich sequence-binding
protein 1 (SATB1) and colorectal cancer (CRC) has not been reported. This study was …

Background: Special AT-rich sequence-binding protein 2 (SATB2) is a novel diagnostic
marker of colorectal cancer (CRC), and loss of SATB2 has been linked to poor survival from …

Special AT-rich sequence binding protein 1 (SATB1), a new type of gene regulator, has
been reported to express in various human cancers and may associate with the malignant …

Background SATB1 is a nuclear protein that has been recently reported to be a'genome
organizer'which delineates specific epigenetic modifications at target gene loci, directly up …

The primary origin of some ovarian mucinous tumors may be challenging to determine,
because some metastases of extraovarian origin may exhibit gross, microscopic, and …

Background Special AT‐rich binding protein‐1 (SATB 1) reprograms chromatin organization
and transcription profiles to promote tumour growth and metastasis. Aims This study aimed …